Chemical probes for understudied kinases: challenges and opportunities

Journal article

Over 20 years after the approval of the first-in-class protein kinase inhibitor imatinib, the biological function of a significant fraction of the human kinome remains poorly understood while most research continues to be focused on few well-validated targets. Given the strong genetic evidence for involvement of many kinases in health and disease, the understudied fraction of the kinome holds a large and unexplored potential for future therapies. Specific chemical probes are indispensable tools to interrogate biology enabling proper preclinical validation of novel kinase targets. In this Perspective, we highlight recent case studies illustrating the development of high-quality chemical probes for less-studied kinases and their application in target validation. We spotlight emerging techniques and approaches employed in the generation of chemical probes for protein kinases and beyond and discuss the associated challenges and opportunities.

Authors: Serafim, RAM; Elkins, JM; Zuercher, WJ; Laufer, SA; Gehringer, M

• Publication status: Published
• Peer review status: Peer reviewed
• Publisher: American Chemical Society
• Journal: Journal of Medicinal Chemistry
• Volume: 65
• Issue: 2
• Pages: 1132–1170
• Publication date: 2021-09-03
• Acceptance date: 2021-08-20
• DOI: 10.1021/acs.jmedchem.1c00980
• EISSN: 1520-4804
• ISSN: 0022-2623
• Pmid: 34477374
• Language: English
• Keywords: FFR